FDA Grants Accelerated Approval to Enhertu for Subgroup of Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

Use of Potentially Inappropriate Medications Associated With Increased Risks for Poor Outcomes in Older Patients With Cancer

FDA Grants Tabrecta a Regular Approval for Certain Patients With Lung Cancer

Crying Over a Movie, Cancer and Lost Innocence